Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma

Anticancer Research

Volumn 20, Issue 5, 2000, Pages 3045-3049

  Riedel, F ^a   Gotte, K ^a   Schwalb, J ^a   Hormann, K ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Head and neck squamous cell carcinoma; Matrix metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING;

EID: 0033792767     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Regulation of tumor cell invasion by extracellular matrix
2. Tumor invasion: Role of the extracellular matrix
3. Changing view of the role of matrix metalloproteinases in metastases
4. The basement membrane in pathology
5. Structural properties of matrix metalloproteinases
6. Evaluation of some newer matrix metalloproteinases
7. Metalloproteinases in tumor progression: The contribution of MMP-9
8. Matrix metalloproteinases and metastatic cancer
9. Matrix metalloproteinases and their inhibitors
10. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications
11. Matrix metalloproteinases and metastasis
12. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma
13. Matrix metalloproteinases: Biologic activity and clinical implications
14. Regulation of matrix metalloproteinase expression in tumor invasion
15. Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancer
16. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma
17. Evaluation of basement membrane components and the 72 KDa type IV collagenase in serous tumors of the ovary
18. Augmentation of type IV collagenase, laminin receptor and Ki67 proliferation antigen associated with human colon, gastric and breast carcinoma progression
19. Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients
20. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer
21. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase / gelatinase B) in hepatocellular carcinoma
22. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study
23. Expression of MMPS, MT-MMP and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasis
24. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization
25. Proteolytic patterns of head and neck squamous cell carcinoma
26. Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: A potentially useful laboratory marker
27. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes
28. Angiogenesis
29. Complex role of matrix metalloproteinases in angiogenesis
30. Expression of basic fibroblast growth factor and its down-regulation by interferons in head and neck cancer
31. Vascular endothelial growth factor expression correlates with p53 mutation and angiogenesis in squamous cell carcinoma of the head and neck
32. Serum levels of vascular endothelial growth factor in patients with head and neck cancer